Infinity Pharmaceuticals, Inc. Total Assets
Infinity Pharmaceuticals, Inc. had Total Assets of $21.23 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2023-08-10
- 2023-06-30: Assets $21.23M.
- 2023-03-31: Assets $29.95M.
- 2022-12-31: Assets $42.15M.
- 2022-09-30: Assets $51.59M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2023-06-30 | $21.23M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $29.95M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $42.15M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $51.59M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $61.86M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $72.58M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $84.78M 10-K · filed 2023-03-28 | |
| 2021-09-30 | $94.61M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $102.60M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $112.40M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $39.32M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $46.97M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $48.66M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $57.09M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $49.01M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $59.11M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $68.44M 10-Q · filed 2019-07-30 | |
| 2019-03-31 | $74.75M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $60.22M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $65.91M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $51.27M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $49.97M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $59.35M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $64.27M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $90.84M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $103.61M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $125.66M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $151.90M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $187.29M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $240.50M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $288.82M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $333.23M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $240.88M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $267.64M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $369.14M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $396.82M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $165.59M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $199.78M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $230.71M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $260.81M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $287.72M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $313.49M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $335.66M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $198.19M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $113.05M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $114.92M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $124.49M 10-K · filed 2013-03-05 | $124.49M 10-K · filed 2012-03-13 |
| 2011-09-30 | $97.70M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $104.80M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $124.57M 10-K · filed 2012-03-13 |